NCT07027618 · NOT YET RECRUITING
AI-Driven Personalization of End-of-Life Care for the Elderly
This trial tests whether AI-based software can improve end-of-life care for older adults. It uses wearable sensors, medication reminders, and alerts to the care team. Researchers will track quality of life, falls, emergency hospital visits, and caregiver burden over six months. Phase is not applicable, which is typical for software and care-delivery studies rather than drug trials.
Eligibility criteria
Inclusion Criteria: Age ≥ 60 years Clinical diagnosis of being in the end-of-life stage, based on criteria such as the Karnofsky Performance Scale or Palliative Performance Scale Informed consent obtained from the participant or legal representative Ability to use technology independently or with support provided by the research team Access to necessary equipment for the intervention (e.g., wearable sensors, smartphone/tablet) Exclusion Criteria: Presence of severe cognitive impairment preventing software use Voluntary withdrawal from the study at any stage Critical medical deterioration or death during the study Poor adherence or insufficient engagement with the intervention software in the intervention group
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-06-18